Drug Type Exosomes |
Synonyms SOB 101, SOB101 |
Target |
Action modulators |
Mechanism HLA-G modulators(major histocompatibility complex, class I, G modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | Taiwan Province | 01 Jun 2026 | |
| Ovarian Cancer | Discovery | Taiwan Province | 11 Aug 2023 |





